Monday, July 06, 2020 9:44:37 AM
– Primary endpoint of placebo-adjusted reduction in awake cough frequency did not reach statistical significance –
https://www.google.com/amp/s/business.financialpost.com/pmn/press-releases-pmn/business-wire-news-releases-pmn/bellus-health-announces-topline-results-from-its-phase-2-relief-trial-of-blu-5937-for-the-treatment-of-refractory-chronic-cough/amp
B. O. B.
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM